These results may enhance our understanding of the mechanism underlying NLRP3 inflammasome activation and the effectiveness of BTK inhibitors for the treatment of acute inflammatory diseases including ischaemic stroke. This evidence concerns the gene NLRP3 and ischemic stroke.